Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000-2017, USA.

Durham MD, Armon C, Mahnken JD, Novak RM, Palella F, Tedaldi E, Buchacz K; HOPS Investigators.

Prev Med. 2020 Feb 3:106011. doi: 10.1016/j.ypmed.2020.106011. [Epub ahead of print]

PMID:
32027915
2.

A community-based model of HIV care for men who have sex with men and transgender women in Chicago.

Brito MO, Khosla S, Santana L, Lubrano A, Martinez T, Eugeni A, Mehta SD, Novak RM.

Int J STD AIDS. 2020 Feb;31(2):150-157. doi: 10.1177/0956462419886779. Epub 2020 Jan 22. No abstract available.

PMID:
31969060
3.

Chlamydia and Gonorrhea Incidence and Testing among Patients in the HIV Outpatient Study, 2007-2017.

Li J, Armon C, Palella FJ, Novak RM, Ward D, Purinton S, Durham M, Buchacz K; HIV Outpatient Study (HOPS) Investigators.

Clin Infect Dis. 2019 Nov 6. pii: ciz1085. doi: 10.1093/cid/ciz1085. [Epub ahead of print]

PMID:
31689341
4.

Simplification of ART in a patient living with multidrug resistant HIV-1: A case report using twice daily cobicistat and darunavir.

Brizzi MB, Novak RM, Chiampas TD.

Int J STD AIDS. 2019 Nov;30(13):1333-1336. doi: 10.1177/0956462419841130. Epub 2019 Oct 20. No abstract available.

PMID:
31631777
5.

Mycobacterium conceptionense Pneumonitis in Patient with HIV/AIDS1.

Michienzi SM, Burgos RM, Novak RM.

Emerg Infect Dis. 2019 Oct;25(10):1986-1988. doi: 10.3201/eid2510.190444.

6.

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.

Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak RM, Frank I, McElrath MJ, Tomaras GD, Geraghty DE, Peng X.

J Virol. 2019 Oct 15;93(21). pii: e02041-18. doi: 10.1128/JVI.02041-18. Print 2019 Nov 1.

PMID:
31434737
7.

Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial.

Van Wagoner N, Fife K, Leone PA, Bernstein DI, Warren T, Panther L, Novak RM, Beigi R, Kriesel J, Tyring S, Koltun W, Lucksinger G, Morris A, Zhang B, McNeil LK, Tasker S, Hetherington S, Wald A.

J Infect Dis. 2018 Nov 5;218(12):1890-1899. doi: 10.1093/infdis/jiy415.

PMID:
29982727
8.

Time spent with HIV viral load above 1500 copies/ml among patients in HIV care, 2000-2014.

Mendoza MCB, Gardner L, Armon C, Rose CE, Palella FJ Jr, Novak RM, Tedaldi EM, Buchacz K; HIV Outpatient Study Investigators.

AIDS. 2018 Sep 10;32(14):2033-2042. doi: 10.1097/QAD.0000000000001921.

PMID:
29958190
9.

Risk Factors and Incidence of Syphilis in Human Immunodeficiency Virus (HIV)-Infected Persons: The HIV Outpatient Study, 1999-2015.

Novak RM, Ghanem A, Hart R, Ward D, Armon C, Buchacz K; HIV Outpatient Study Investigators.

Clin Infect Dis. 2018 Nov 13;67(11):1750-1759. doi: 10.1093/cid/ciy348.

PMID:
29688270
10.

A flow-chart for developing water quality criteria from two field-based methods.

Cormier SM, Zheng L, Hill RA, Novak RM, Flaherty CM.

Sci Total Environ. 2018 Aug 15;633:1647-1656. doi: 10.1016/j.scitotenv.2018.01.137. Epub 2018 Feb 1.

PMID:
29395232
11.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.

Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, Carpp LN, Hammer SM, Sobieszczyk M, Karuna S, Swann E, DeJesus E, Mulligan M, Frank I, Buchbinder S, Novak RM, McElrath MJ, Kalams S, Keefer M, Frahm NA, Janes HE, Gilbert PB, Tomaras GD.

J Infect Dis. 2018 Mar 28;217(8):1280-1288. doi: 10.1093/infdis/jiy008.

12.

Disparities in HIV Viral Load Suppression by Race/ethnicity among Men who Have Sex with Men in the HIV Outpatient Study.

Buchacz K, Armon C, Tedaldi E, Palella FJ, Novak RM, Ward D, Hart R, Durham M, Brooks J.

AIDS Res Hum Retroviruses. 2018 Jan 9. doi: 10.1089/AID.2017.0162. [Epub ahead of print]

PMID:
29316797
13.

Sexually Transmitted Disease Testing of Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: Room for Improvement.

Dean BB, Scott M, Hart R, Battalora L, Novak RM, Durham MD, Brooks JT, Buchacz K; HIV Outpatient Study (HOPS) Investigators.

Sex Transm Dis. 2017 Nov;44(11):678-684. doi: 10.1097/OLQ.0000000000000664.

PMID:
28876305
14.

Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.

Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, DʼSouza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):382-390. doi: 10.1097/QAI.0000000000001394.

15.

HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.

Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA).

Clin Infect Dis. 2017 Feb 15;64(4):468-475. doi: 10.1093/cid/ciw764.

16.

Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract.

Zevin AS, Xie IY, Birse K, Arnold K, Romas L, Westmacott G, Novak RM, McCorrister S, McKinnon LR, Cohen CR, Mackelprang R, Lingappa J, Lauffenburger DA, Klatt NR, Burgener AD.

PLoS Pathog. 2016 Sep 22;12(9):e1005889. doi: 10.1371/journal.ppat.1005889. eCollection 2016 Sep.

17.

CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk.

Palella FJ Jr, Armon C, Chmiel JS, Brooks JT, Hart R, Lichtenstein K, Novak RM, Yangco B, Wood K, Durham M, Buchacz K; HOPS Investigators.

J Antimicrob Chemother. 2016 Sep;71(9):2654-62. doi: 10.1093/jac/dkw196. Epub 2016 Jun 20.

PMID:
27330061
18.

A Matter of Perspective: Comparison of the Characteristics of Persons with HIV Infection in the United States from the HIV Outpatient Study, Medical Monitoring Project, and National HIV Surveillance System.

Buchacz K, Frazier EL, Hall HI, Hart R, Huang P, Franklin D, Hu X, Palella FJ, Chmiel JS, Novak RM, Wood K, Yangco B, Armon C, Brooks JT, Skarbinski J.

Open AIDS J. 2015 Dec 7;9:123-33. doi: 10.2174/1874613601509010123. eCollection 2015.

19.

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Ann Intern Med. 2015 Oct 6;163(7):507-18. doi: 10.7326/M14-2768.

20.

In vitro antiretroviral activity and in vivo toxicity of the potential topical microbicide copper phthalocyanine sulfate.

Styczynski AR, Anwar KN, Sultana H, Ghanem A, Lurain N, Chua A, Ghassemi M, Novak RM.

Virol J. 2015 Aug 30;12:132. doi: 10.1186/s12985-015-0358-5.

21.

Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.

Birse K, Arnold KB, Novak RM, McCorrister S, Shaw S, Westmacott GR, Ball TB, Lauffenburger DA, Burgener A.

J Virol. 2015 Sep;89(17):8793-805. doi: 10.1128/JVI.00756-15. Epub 2015 Jun 17.

22.

T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN.

Jarrett OD, Brady KE, Modur SP, Plants J, Landay AL, Ghassemi M, Golub ET, Spear GT, Novak RM.

PLoS One. 2015 Jun 17;10(6):e0130146. doi: 10.1371/journal.pone.0130146. eCollection 2015.

23.

Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects.

Justo JA, Mayer SM, Pai MP, Soriano MM, Danziger LH, Novak RM, Rodvold KA.

Antimicrob Agents Chemother. 2015 Jul;59(7):3956-65. doi: 10.1128/AAC.00498-15. Epub 2015 Apr 20.

24.

Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013.

Novak RM, Hart RL, Chmiel JS, Brooks JT, Buchacz K; HIV Outpatient Study (HOPS) Investigators.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):23-32. doi: 10.1097/QAI.0000000000000652.

PMID:
25886926
25.

HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906.

Koblin BA, Grant S, Frye V, Superak H, Sanchez B, Lucy D, Dunbar D, Graham P, Madenwald T, Escamilia G, Swann E, Morgan C, Novak RM, Frank I; HVTN 906 study team.

J Urban Health. 2015 Jun;92(3):572-83. doi: 10.1007/s11524-015-9944-5.

26.

Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.

Patel P, Armon C, Chmiel JS, Brooks JT, Buchacz K, Wood K, Novak RM.

Open Forum Infect Dis. 2014 May 27;1(1):ofu012. doi: 10.1093/ofid/ofu012. eCollection 2014 Mar.

27.

Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Law MG, Achhra A, Deeks SG, Gazzard B, Migueles SA, Novak RM, Ristola M; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:37-45. doi: 10.1111/hiv.12232.

28.

Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery.

Pitrak DL, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL.

AIDS Res Hum Retroviruses. 2015 Feb;31(2):208-16. doi: 10.1089/aid.2014.0038. Epub 2014 Nov 11.

29.

Feasibility of universal HIV testing in an outpatient clinic.

Turin SY, Rosenfield RE, Lee M, Patel K, Novak RM.

Clin Infect Dis. 2014 Oct 15;59(8):1186-7. doi: 10.1093/cid/ciu554. Epub 2014 Jul 14. No abstract available.

PMID:
25028462
30.

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

Palella FJ Jr, Armon C, Buchacz K, Chmiel JS, Novak RM, D'Aquila RT, Brooks JT; HOPS Investigators.

J Antimicrob Chemother. 2014 Oct;69(10):2826-34. doi: 10.1093/jac/dku190. Epub 2014 Jun 16.

PMID:
24942257
31.

Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study.

McKinnon LR, Hughes SM, De Rosa SC, Martinson JA, Plants J, Brady KE, Gumbi PP, Adams DJ, Vojtech L, Galloway CG, Fialkow M, Lentz G, Gao D, Shu Z, Nyanga B, Izulla P, Kimani J, Kimwaki S, Bere A, Moodie Z, Landay AL, Passmore JA, Kaul R, Novak RM, McElrath MJ, Hladik F.

PLoS One. 2014 Jan 15;9(1):e85675. doi: 10.1371/journal.pone.0085675. eCollection 2014.

32.

Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection.

Birse KM, Burgener A, Westmacott GR, McCorrister S, Novak RM, Ball TB.

PLoS One. 2013 Nov 14;8(11):e79505. doi: 10.1371/journal.pone.0079505. eCollection 2013.

33.

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, Adams E, DeJesus E, Novak RM, Frank I, Bentley C, Ramirez S, Fu R, Koup RA, Mascola JR, Nabel GJ, Montefiori DC, Kublin J, McElrath MJ, Corey L, Gilbert PB; HVTN 505 Study Team.

N Engl J Med. 2013 Nov 28;369(22):2083-92. doi: 10.1056/NEJMoa1310566. Epub 2013 Oct 7.

34.

Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.

Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa JP, Abdul-Jauwad H, Joseph P, Koenig E, Metzger D, Sobieszycz M, Tyndall M, Zorilla C.

AIDS. 2013 Jul 17;27(11):1763-70. doi: 10.1097/QAD.0b013e328360c83e. Erratum in: AIDS. 2013 Sep 10;27(14):2321. Adbul-Jauwad, Hend [corrected to Abdul-Jauwad, Hend].

35.

Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.

Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G, Frank I; HVTN 906 Study Team.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):239-44. doi: 10.1097/QAI.0b013e31828ded1a.

36.

IL-22 levels are associated with Trichomonas vaginalis infection in the lower genital tract.

Makinde HM, Zariffard R, Mirmonsef P, Novak RM, Jarrett O, Landay AL, Spear GT.

Am J Reprod Immunol. 2013 Jul;70(1):38-44. doi: 10.1111/aji.12100. Epub 2013 Feb 27.

37.

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus.

McElrath MJ, Smythe K, Randolph-Habecker J, Melton KR, Goodpaster TA, Hughes SM, Mack M, Sato A, Diaz G, Steinbach G, Novak RM, Curlin ME, Lord JD, Maenza J, Duerr A, Frahm N, Hladik F; NIAID HIV Vaccine Trials Network.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):263-71. doi: 10.1097/QAI.0b013e3182898392. Erratum in: J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):323. Curlin, M [corrected to Curlin, Marcel E].

38.

Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.

Martin GE, Gouillou M, Hearps AC, Angelovich TA, Cheng AC, Lynch F, Cheng WJ, Paukovics G, Palmer CS, Novak RM, Jaworowski A, Landay AL, Crowe SM.

PLoS One. 2013;8(1):e55279. doi: 10.1371/journal.pone.0055279. Epub 2013 Jan 24.

39.

Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008.

Buchacz K, Baker R, Ward DJ, Palella FJ, Chmiel JS, Young B, Yangco BG, Novak RM, Brooks JT.

AIDS Res Treat. 2012;2012:230290. doi: 10.1155/2012/230290. Epub 2012 Mar 14.

40.

Immune reconstitution inflammatory syndrome: incidence and implications for mortality.

Novak RM, Richardson JT, Buchacz K, Chmiel JS, Durham MD, Palella FJ, Wendrow A, Wood K, Young B, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

AIDS. 2012 Mar 27;26(6):721-30. doi: 10.1097/QAD.0b013e3283511e91.

41.

Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.

Palella FJ Jr, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT; HOPS Investigators.

AIDS. 2011 Sep 24;25(15):1865-76. doi: 10.1097/QAD.0b013e32834b3537.

PMID:
21811144
42.

Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, Adeyemi O, Spear GT.

Altern Ther Health Med. 2011 Mar-Apr;17(2):30-5.

43.

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.

Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA, Bohjanen PR, Novak RM, Neaton JD, Sereti I; INSIGHT Study Group.

J Infect Dis. 2011 Jun 1;203(11):1637-46. doi: 10.1093/infdis/jir134.

44.

Beneficial effects of a switch to a Lopinavir/ritonavir-containing regimen for patients with partial or no immune reconstitution with highly active antiretroviral therapy despite complete viral suppression.

Pitrak DL, Estes R, Novak RM, Linnares-Diaz M, Tschampa JM.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):659-67. doi: 10.1089/AID.2010.0230. Epub 2010 Dec 16.

PMID:
21054216
45.

AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.

Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT; HOPS Investigators.

AIDS. 2010 Jun 19;24(10):1549-59. doi: 10.1097/QAD.0b013e32833a3967.

PMID:
20502317
46.

Implementing universal oral HIV screening in an urban emergency department-do demographic characteristics impact acceptance of testing?

Trotter AB, Bhayani N, Florsheim R, Novak RM.

Clin Infect Dis. 2010 Jan 15;50(2):283. doi: 10.1086/649549. No abstract available.

PMID:
20034354
47.

The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.

Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman AC, Brooks JT; HOPS (HIV Outpatient Study) Investigators.

Ann Intern Med. 2009 Jul 21;151(2):73-84.

PMID:
19620160
48.

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.

Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ; Terry Beirn Community Programs for Clinical Research on AIDS.

J Infect Dis. 2009 Mar 1;199(5):693-701. doi: 10.1086/596736.

PMID:
19210162
49.

Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.

van den Berg-Wolf M, Hullsiek KH, Peng G, Kozal MJ, Novak RM, Chen L, Crane LR, Macarthur RD; CPCRA 058 Study Team, the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA), and The International Network for Strategic Initiative in Global HIV Trials (INSIGHT).

HIV Clin Trials. 2008 Sep-Oct;9(5):324-36. doi: 10.1310/hct0905-324.

PMID:
18977721
50.

Interferon-gamma receptors in HIV-1 infection.

Koirala J, Adamski A, Koch L, Stueber D, El-Azizi M, Khardori NM, Ghassemi M, Novak RM.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1097-102. doi: 10.1089/aid.2007.0261.

PMID:
18620489

Supplemental Content

Loading ...
Support Center